Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Stellar Biotech, Inc. (SBOTF) Starts Presentation at 2015 Marcum MicroCap Conference

Stellar Biotechnologies is a biotechnology company with efforts focused on the aquaculture, research and development, manufactur, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, United States and Asia. KLH is an immune-stimulating protein used for generation of antibody and cell-mediated immune responses against disease indications, such as cancer, immune disorders, Alzheimers, and inflammatory diseases. For more information, visit the company website at

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.